Stock AVCN AVICANNA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Avicanna Inc.

Equities

AVCN

CA05368K1003

Market Closed - Toronto S.E.
Other stock markets
 15:59:59 2024-06-27 EDT 		5-day change 1st Jan Change
0.4 CAD +15.94% Intraday chart for Avicanna Inc. +45.45% +14.29%
06-19 US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology MT
06-19 Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avicanna General Meeting
AQ
US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology
MT
Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology
MT
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
AQ
Avicanna Announces United States Patent and Trademark Office Issuance of Patent SEDDS Technology
CI
Avicanna to Present at the Life Science Investor Forum June 20th, 2024
AQ
Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History
MT
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History
MT
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023
MT
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
AQ
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa
MT
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa
MT
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
AQ
Avicanna Inc. Announces Results of Study in Patients with Epidermolysis Bullosa
CI
Avicanna Raises About $2.1 Million in Non-brokered Private Placement
MT
Avicanna Announces Closing of Non-brokered Private Placement
AQ
Avicanna Inc. announced that it has received CAD 2.125584 million in funding
CI
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
AQ
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVCN Stock
  4. News Avicanna Inc.